Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography | 12 | 2018 | 459 | 1.670 |
Why?
|
| Point-of-Care Systems | 6 | 2018 | 120 | 1.150 |
Why?
|
| Emergency Medicine | 4 | 2015 | 181 | 0.770 |
Why?
|
| Clinical Competence | 5 | 2015 | 683 | 0.740 |
Why?
|
| Blood Volume | 3 | 2018 | 42 | 0.710 |
Why?
|
| Ultrasonography, Interventional | 3 | 2011 | 92 | 0.660 |
Why?
|
| Abscess | 4 | 2014 | 76 | 0.620 |
Why?
|
| Wounds and Injuries | 2 | 2018 | 229 | 0.610 |
Why?
|
| Carotid Arteries | 2 | 2015 | 62 | 0.560 |
Why?
|
| Pneumothorax | 1 | 2016 | 49 | 0.520 |
Why?
|
| Learning Curve | 1 | 2015 | 30 | 0.480 |
Why?
|
| Staphylococcal Skin Infections | 2 | 2014 | 13 | 0.470 |
Why?
|
| Dehydration | 1 | 2014 | 15 | 0.450 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2014 | 62 | 0.450 |
Why?
|
| Fluid Therapy | 1 | 2014 | 47 | 0.440 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 108 | 0.440 |
Why?
|
| Drainage | 3 | 2012 | 149 | 0.380 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 4 | 2021 | 46 | 0.380 |
Why?
|
| Internship and Residency | 4 | 2015 | 746 | 0.380 |
Why?
|
| Prospective Studies | 10 | 2021 | 3067 | 0.360 |
Why?
|
| Radiology | 1 | 2015 | 238 | 0.360 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 61 | 0.350 |
Why?
|
| Vena Cava, Inferior | 1 | 2009 | 28 | 0.310 |
Why?
|
| Gallbladder Diseases | 1 | 2008 | 26 | 0.300 |
Why?
|
| Optic Nerve | 1 | 2008 | 25 | 0.300 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 95 | 0.280 |
Why?
|
| Advanced Cardiac Life Support | 2 | 2017 | 14 | 0.280 |
Why?
|
| Radiography, Abdominal | 1 | 2006 | 27 | 0.260 |
Why?
|
| Abdomen | 1 | 2006 | 91 | 0.260 |
Why?
|
| Hemorrhage | 2 | 2018 | 260 | 0.240 |
Why?
|
| Sensitivity and Specificity | 5 | 2016 | 1093 | 0.230 |
Why?
|
| Heart Arrest | 2 | 2017 | 161 | 0.230 |
Why?
|
| Emergency Service, Hospital | 5 | 2017 | 1021 | 0.220 |
Why?
|
| Educational Measurement | 2 | 2015 | 211 | 0.210 |
Why?
|
| Adult | 10 | 2018 | 15669 | 0.190 |
Why?
|
| Humans | 20 | 2021 | 59360 | 0.190 |
Why?
|
| Male | 14 | 2018 | 27739 | 0.190 |
Why?
|
| Heart Failure | 1 | 2009 | 853 | 0.180 |
Why?
|
| Female | 14 | 2018 | 30705 | 0.180 |
Why?
|
| Education, Medical, Graduate | 3 | 2015 | 317 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 85 | 0.170 |
Why?
|
| Hypovolemia | 1 | 2018 | 16 | 0.150 |
Why?
|
| Support Vector Machine | 1 | 2018 | 21 | 0.150 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2018 | 10 | 0.150 |
Why?
|
| Photoplethysmography | 1 | 2018 | 33 | 0.150 |
Why?
|
| Time Factors | 2 | 2016 | 3617 | 0.140 |
Why?
|
| Lung Injury | 1 | 2016 | 32 | 0.130 |
Why?
|
| Middle Aged | 6 | 2017 | 16317 | 0.130 |
Why?
|
| Confidence Intervals | 2 | 2014 | 241 | 0.130 |
Why?
|
| Ischemic Preconditioning, Myocardial | 3 | 2004 | 22 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 1526 | 0.120 |
Why?
|
| Decision Trees | 1 | 2014 | 51 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2017 | 6071 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 206 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 131 | 0.110 |
Why?
|
| Jejunum | 2 | 2002 | 14 | 0.100 |
Why?
|
| Heart Rate | 1 | 2014 | 307 | 0.100 |
Why?
|
| Aged | 5 | 2017 | 13416 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2014 | 495 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5128 | 0.090 |
Why?
|
| Curriculum | 1 | 2015 | 558 | 0.090 |
Why?
|
| Jugular Veins | 1 | 2010 | 29 | 0.090 |
Why?
|
| Ischemia | 2 | 2002 | 199 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 60 | 0.090 |
Why?
|
| Critical Care | 1 | 2014 | 397 | 0.080 |
Why?
|
| Myocardium | 2 | 2002 | 264 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2010 | 84 | 0.080 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2009 | 21 | 0.080 |
Why?
|
| Soft Tissue Infections | 1 | 2009 | 45 | 0.080 |
Why?
|
| Skin Diseases | 1 | 2009 | 76 | 0.080 |
Why?
|
| Respiration | 1 | 2009 | 88 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1561 | 0.070 |
Why?
|
| Dyspnea | 1 | 2009 | 116 | 0.070 |
Why?
|
| Naloxone | 3 | 2004 | 57 | 0.070 |
Why?
|
| Young Adult | 2 | 2014 | 4267 | 0.070 |
Why?
|
| Echocardiography | 2 | 2021 | 457 | 0.070 |
Why?
|
| Imino Acids | 1 | 2006 | 3 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2015 | 914 | 0.070 |
Why?
|
| Gallstones | 1 | 2006 | 24 | 0.070 |
Why?
|
| Cholecystitis | 1 | 2006 | 27 | 0.070 |
Why?
|
| Videotape Recording | 1 | 2006 | 46 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 57 | 0.060 |
Why?
|
| United States | 2 | 2016 | 7390 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 95 | 0.060 |
Why?
|
| Narcotics | 1 | 2004 | 50 | 0.060 |
Why?
|
| Apnea | 1 | 2004 | 30 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 705 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 111 | 0.050 |
Why?
|
| Heart | 2 | 2004 | 274 | 0.050 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 1 | 2002 | 2 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2002 | 14 | 0.050 |
Why?
|
| Receptors, Opioid, delta | 1 | 2002 | 5 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2002 | 53 | 0.050 |
Why?
|
| Rabbits | 4 | 2004 | 322 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 49 | 0.050 |
Why?
|
| Electric Countershock | 1 | 2021 | 99 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 2337 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 687 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2011 | 5284 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2021 | 523 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2017 | 15 | 0.040 |
Why?
|
| Epinephrine | 1 | 2017 | 41 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 61 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2002 | 471 | 0.030 |
Why?
|
| Canada | 1 | 2016 | 147 | 0.030 |
Why?
|
| Supine Position | 1 | 2015 | 31 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 9 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 68 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 33 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 555 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1051 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 205 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 801 | 0.030 |
Why?
|
| Community-Acquired Infections | 1 | 2014 | 92 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 976 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 185 | 0.020 |
Why?
|
| Narcotic Antagonists | 2 | 2004 | 121 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 266 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 409 | 0.020 |
Why?
|
| Muscle Contraction | 2 | 2002 | 197 | 0.020 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 13 | 0.020 |
Why?
|
| Manikins | 1 | 2010 | 19 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1232 | 0.020 |
Why?
|
| Punctures | 1 | 2010 | 56 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1486 | 0.020 |
Why?
|
| Subcutaneous Tissue | 1 | 2009 | 14 | 0.020 |
Why?
|
| Cellulitis | 1 | 2009 | 22 | 0.020 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2009 | 34 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 1782 | 0.020 |
Why?
|
| Massachusetts | 1 | 2014 | 2002 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1237 | 0.020 |
Why?
|
| Skin | 1 | 2009 | 357 | 0.020 |
Why?
|
| Child | 1 | 2014 | 4174 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2513 | 0.010 |
Why?
|
| Animals | 4 | 2004 | 19651 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 2374 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 5824 | 0.010 |
Why?
|
| Glyburide | 1 | 2002 | 4 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 2002 | 12 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 2002 | 24 | 0.010 |
Why?
|
| Mesentery | 1 | 2002 | 15 | 0.010 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 16 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 225 | 0.010 |
Why?
|
| Enkephalin, Leucine | 1 | 2001 | 7 | 0.010 |
Why?
|
| Enkephalin, Methionine | 1 | 2001 | 9 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2001 | 63 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 137 | 0.010 |
Why?
|
| Hypoxia | 1 | 2002 | 112 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 192 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 806 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2001 | 230 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 445 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 2050 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 862 | 0.010 |
Why?
|